Literature DB >> 23321057

Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms.

Jeannie Chin1, Helen E Scharfman.   

Abstract

Seizures in patients with Alzheimer's disease (AD) have been examined by many investigators over the last several decades, and there are diverse opinions about their potential relevance to AD pathophysiology. Some studies suggest that seizures appear to be a fairly uncommon co-morbidity, whereas other studies report a higher incidence of seizures in patients with AD. It was previously thought that seizures play a minor role in AD pathophysiology because of their low frequency, and also because they may only be noticed during late stages of AD, suggesting that seizures are likely to be a consequence of neurodegeneration rather than a contributing factor. However, clinical reports indicate that seizures can occur early in the emergence of AD symptoms, particularly in familial AD. In this case, seizures may be an integral part of the emerging pathophysiology. This view has been supported by evidence of recurrent spontaneous seizures in transgenic mouse models of AD in which familial AD is simulated. Additional data from transgenic animals suggest that there may be a much closer relationship between seizures and AD than previously considered. There is also evidence that seizures facilitate production of amyloid β (Aβ) and can cause impairments in cognition and behavior in both animals and humans. However, whether seizures play a role in the early stages of AD pathogenesis is still debated. Therefore, it is timely to review the similarities and differences between AD and epilepsy, as well as data suggesting that seizures may contribute to cognitive and behavioral dysfunction in AD. Here we focus on AD and temporal lobe epilepsy (TLE), a particular type of epilepsy that involves the temporal lobe, a region that influences behavior and is critical to memory. We also consider potential neurobiological mechanisms that support the view that the causes of seizures in TLE may be related to the causes of cognitive dysfunction in AD. We suggest that similar underlying mechanisms may exist for at least some of the aspects of AD that are also found in TLE.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23321057      PMCID: PMC3924321          DOI: 10.1016/j.yebeh.2012.11.040

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  134 in total

1.  Endogenous 5-HT inhibits firing activity of hippocampal CA1 pyramidal neurons during conditioned fear stress-induced freezing behavior through stimulating 5-HT1A receptors.

Authors:  Koji Tada; Kimihiro Kasamo; Tadashi Suzuki; Yamato Matsuzaki; Takuya Kojima
Journal:  Hippocampus       Date:  2004       Impact factor: 3.899

2.  Seizures in Alzheimer's disease: a retrospective study of a cohort of outpatients.

Authors:  Silvia Bernardi; Nicola Scaldaferri; Nicola Vanacore; Alessandro Trebbastoni; Ada Francia; Aurelio D'Amico; Massimiliano Prencipe
Journal:  Epileptic Disord       Date:  2010-02-22       Impact factor: 1.819

3.  Hippocampal CA1 kindling but not long-term potentiation disrupts spatial memory performance.

Authors:  L Stan Leung; Bixia Shen
Journal:  Learn Mem       Date:  2006-01-17       Impact factor: 2.460

4.  Neuropeptide Y expression in animal models of temporal lobe epilepsy.

Authors:  G Sperk; R Bellmann; B Gruber; S Greber; J Marksteiner; C Röder; E Rupp
Journal:  Epilepsy Res Suppl       Date:  1996

Review 5.  Presenilin-1 mutation Alzheimer's disease: a genetic epilepsy syndrome?

Authors:  A J Larner
Journal:  Epilepsy Behav       Date:  2011-04-17       Impact factor: 2.937

6.  Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy.

Authors:  Rimante Minkeviciene; Sylvain Rheims; Marton B Dobszay; Misha Zilberter; Jarmo Hartikainen; Lívia Fülöp; Botond Penke; Yuri Zilberter; Tibor Harkany; Asla Pitkänen; Heikki Tanila
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

7.  Quantitative MRI of the prefrontal cortex and executive function in patients with temporal lobe epilepsy.

Authors:  Simon Sean Keller; Gus Baker; Joseph John Downes; Neil Roberts
Journal:  Epilepsy Behav       Date:  2009-04-11       Impact factor: 2.937

Review 8.  Epilepsy, psychosocial and cognitive functioning.

Authors:  Jane McCagh; John E Fisk; Gus A Baker
Journal:  Epilepsy Res       Date:  2009-07-18       Impact factor: 3.045

9.  Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity.

Authors:  Giuseppina Tesco; Young Ho Koh; Eugene L Kang; Andrew N Cameron; Shinjita Das; Miguel Sena-Esteves; Mikko Hiltunen; Shao-Hua Yang; Zhenyu Zhong; Yong Shen; James W Simpkins; Rudolph E Tanzi
Journal:  Neuron       Date:  2007-06-07       Impact factor: 17.173

10.  BACE1 gene deletion: impact on behavioral function in a model of Alzheimer's disease.

Authors:  Dione Kobayashi; Michelle Zeller; Tracy Cole; Manuel Buttini; Lisa McConlogue; Sukanto Sinha; Stephen Freedman; Richard G M Morris; Karen S Chen
Journal:  Neurobiol Aging       Date:  2007-02-28       Impact factor: 4.673

View more
  44 in total

1.  Quantitative Imaging Biomarkers of Damage to Critical Memory Regions Are Associated With Post-Radiation Therapy Memory Performance in Brain Tumor Patients.

Authors:  Kathryn R Tringale; Tanya T Nguyen; Roshan Karunamuni; Tyler Seibert; Minh-Phuong Huynh-Le; Michael Connor; Vitali Moiseenko; Mary Kay Gorman; Anisa Marshall; Michelle Devereux Tibbs; Nikdokht Farid; Daniel Simpson; Parag Sanghvi; Carrie R McDonald; Jona A Hattangadi-Gluth
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-08-10       Impact factor: 7.038

2.  Neuronal Network Excitability in Alzheimer's Disease: The Puzzle of Similar versus Divergent Roles of Amyloid β and Tau.

Authors:  Syed Faraz Kazim; Joon Ho Seo; Riccardo Bianchi; Chloe S Larson; Abhijeet Sharma; Robert K S Wong; Kirill Y Gorbachev; Ana C Pereira
Journal:  eNeuro       Date:  2021-04-23

3.  Do Patients With Temporal Lobe Epilepsy and Cognitive Decline Have Alzheimer's Disease or Chronic Traumatic Encephalopathy (CTE)?

Authors:  William B Barr
Journal:  Epilepsy Curr       Date:  2017 Mar-Apr       Impact factor: 7.500

4.  Cognition in Epilepsy: ΔFosB Takes Center Stage (and May Star in the Prologue).

Authors:  Christina Gross
Journal:  Epilepsy Curr       Date:  2018 Sep-Oct       Impact factor: 7.500

5.  Altered Cortical and Hippocampal Excitability in TgF344-AD Rats Modeling Alzheimer's Disease Pathology.

Authors:  Milan Stoiljkovic; Craig Kelley; Bernardo Stutz; Tamas L Horvath; Mihály Hajós
Journal:  Cereb Cortex       Date:  2019-06-01       Impact factor: 5.357

6.  Association Between Childhood-Onset Epilepsy and Amyloid Burden 5 Decades Later.

Authors:  Juho Joutsa; Juha O Rinne; Bruce Hermann; Mira Karrasch; Anu Anttinen; Shlomo Shinnar; Matti Sillanpää
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

7.  Corticothalamic network dysfunction and Alzheimer's disease.

Authors:  Rohan Jagirdar; Jeannie Chin
Journal:  Brain Res       Date:  2017-09-15       Impact factor: 3.252

8.  Widespread changes in network activity allow non-invasive detection of mesial temporal lobe seizures.

Authors:  Alice D Lam; Rodrigo Zepeda; Andrew J Cole; Sydney S Cash
Journal:  Brain       Date:  2016-07-29       Impact factor: 13.501

9.  ΔFosB Regulates Gene Expression and Cognitive Dysfunction in a Mouse Model of Alzheimer's Disease.

Authors:  Brian F Corbett; Jason C You; Xiaohong Zhang; Mark S Pyfer; Umberto Tosi; Daniel M Iascone; Iraklis Petrof; Anupam Hazra; Chia-Hsuan Fu; Gabriel S Stephens; Annie A Ashok; Suzan Aschmies; Lijuan Zhao; Eric J Nestler; Jeannie Chin
Journal:  Cell Rep       Date:  2017-07-11       Impact factor: 9.423

10.  Vitamin C deficiency in the brain impairs cognition, increases amyloid accumulation and deposition, and oxidative stress in APP/PSEN1 and normally aging mice.

Authors:  Shilpy Dixit; Alexandra Bernardo; Jennifer Michelle Walker; John Andrew Kennard; Grace Youngeun Kim; Eric Sean Kessler; Fiona Edith Harrison
Journal:  ACS Chem Neurosci       Date:  2015-02-12       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.